Sublingual immunotherapy provides an early increase of interferon-gamma production

Journal of Biological Regulators and Homeostatic Agents

Volumn 22, Issue 3, 2008, Pages 169-173

  Ciprandi, Giorgio ^a   Fenoglio, D ^a   Di Gioacchino, M ^b   Ferrera, A ^a   Ferrera, F ^a   Sormani, M P ^c   Marseglia, G L ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

Early marker of response; ELISPOT; IFN production; Sublingual immunotherapy; Th1 cells

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MALE; METABOLISM; MIDDLE AGED; PERENNIAL RHINITIS; SUBLINGUAL DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 58949093503     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Plaut M, Valentine MD. Allergic rhinitis. N Engl J Med 2005; 353:1934-44. (Pubitemid 41565958)
2. Finkelman FD, Vercelli D. Advances in asthma, allergy mechanisms, and genetics in 2006. J Allergy Clin Immunol 2007; 120:544-50. (Pubitemid 47320758)
3. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007; 119:881-91. (Pubitemid 46527840)
4. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy organization taskforce. Allergy 2007; 62:317-24.
5. Frew AJ. Immunotherapy of allergic disease. J Allergy Clin Immunol 2003; 111:S712-9.
6. Bousquet J, Lockey RF, Mailing HJ. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy 1998; 53(S):1-42.
7. Mailing HJ, Abreo-Nogueira J, Alvarez-Cuesta E, et al. Local immunotherapy (position paper). Allergy 1998; 53:933-48.
8. Bousquet J, Van Cauwenberg P. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S1-315.
9. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
10. Calamita Z, Saconato H, Bronhara Pelà A, Nagib Atallah A. Efficacy of Sublingual immunotherapy in asthma. Systematic review of randomized clinical trials. Allergy 2006; 61:1162-72. (Pubitemid 44326350)
11. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117:1021-35. (Pubitemid 44308083)
12. Arikan C, Bahceciler NN, Deniz G, et al. Bacillus Calmette-guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 2004; 34:398-405. (Pubitemid 38373002)
13. Cosmi L, Santarlasci V, Angeli R, et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10- production. Clin Exp Allergy 2006; 36:261-72. (Pubitemid 43344707)
14. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Mailing HJ, Valovirta E. Standards for practical allergen-specific immunotherapy. Allergy 2006; 61(S):1-20.
15. Mailing HJ. Sublingual immunotherapy: efficacy-methodology and outcome of clinical trials. Allergy 2006; 61:24-28.
16. Ortolani C, Agostinis F, Amoroso S, et al. Practice parameters for sublingual immunotherapy. Monaldi Arch Chest Dis 2006; 65:44-6. (Pubitemid 43676460)
17. Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Mechin H, Daures JP, Bousquet J. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62: 367-72. (Pubitemid 46398791)
18. Ciprandi G, De Amici M, Murdaca G, Colombo BM, Quaglini S, Marseglia GL, Di Gioacchino M. Serum IL-4 as a marker of immunological response to sublingual immunotherapy. J Biol Reg HA 2008; 22:117-23.
19. Bachert C, Van kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118:375-9. (Pubitemid 29195578)
20. Tang C, Inman MD, van Rooijen N et al. Th type-1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001; 166:1471-81. (Pubitemid 32114625)
21. Jutel M, Akdis M, Blaser K, Akdis CA. Mechanism of allergen specific immunotherapy - T cell tolerance and more. Allergy 2006; 61:796-807. (Pubitemid 43893981)
22. Savolainen J, Nieminem K, Laaksonen K, Laiho T, Jacobsen L, Lahesmaa R, et al. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy. Allergy 2007; 62:949-53. (Pubitemid 47037859)
23. Asemissen AM, Nagorsen D, Keilholz U, et al. Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. J Immunol Methods 2001; 251:101-8. (Pubitemid 32261061)
24. Schmittel A, Keilholz U, Scheibenbogen C. Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J Immunol Methods 1997; 210:167-74. (Pubitemid 28266560)